Skip to main content
. 2021 Dec 2;8:620354. doi: 10.3389/fcvm.2021.620354

Figure 3.

Figure 3

Incremental risk of major bleeding and ischemic endpoints according to the number of ARC-HBR criteria. (A,B) Risk of major bleeding and ischemic endpoints at 2 years for each HBR subgroup. (C) Distribution of HBR patients into subgroups. ARC, Academic Research Consortium; CI, confidence interval; HBR, high bleeding risk; HR, hazard ratio; LBR, low bleeding risk.